+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector"

2024 DNA and RNA Synthesis Research Review - Product Thumbnail Image

2024 DNA and RNA Synthesis Research Review

  • Report
  • March 2025
  • 184 Pages
  • Global
From
Cell and Gene Therapy Tools and Reagents Market - Product Thumbnail Image

Cell and Gene Therapy Tools and Reagents Market

  • Report
  • November 2024
  • 136 Pages
  • Global
From
Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis: Focus on Product Type, Application, Usage, End User, and Region - Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis: Focus on Product Type, Application, Usage, End User, and Region - Analysis and Forecast, 2025-2035

  • Report
  • April 2025
  • 140 Pages
  • Global
From
Infectious Vaccines Market by Vaccine Type, Route of Administration, End User, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Infectious Vaccines Market by Vaccine Type, Route of Administration, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 193 Pages
  • Global
From
Porcine Vaccines Market by Vaccine Type, Disease Indication, End User, Route of Administration, Technology, Dosage Form - Global Forecast to 2030 - Product Thumbnail Image

Porcine Vaccines Market by Vaccine Type, Disease Indication, End User, Route of Administration, Technology, Dosage Form - Global Forecast to 2030

  • Report
  • May 2025
  • 188 Pages
  • Global
From
Cell & Gene Therapy Drug Delivery Devices Market by Device Type, End User, Product Type, Therapy Type, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Cell & Gene Therapy Drug Delivery Devices Market by Device Type, End User, Product Type, Therapy Type, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 183 Pages
  • Global
From
COVID-19 Vaccines Market by Vaccine Technology, Distribution Channel, Dosage Regimen, End User, Application Route, Packaging Type, Procurement Model - Global Forecast to 2030 - Product Thumbnail Image

COVID-19 Vaccines Market by Vaccine Technology, Distribution Channel, Dosage Regimen, End User, Application Route, Packaging Type, Procurement Model - Global Forecast to 2030

  • Report
  • May 2025
  • 186 Pages
  • Global
From
Malaria Vaccine Market by Vaccine Type, Distribution Channel, End User, Route of Administration, Age Group, Dosage Schedule - Global Forecast to 2030 - Product Thumbnail Image

Malaria Vaccine Market by Vaccine Type, Distribution Channel, End User, Route of Administration, Age Group, Dosage Schedule - Global Forecast to 2030

  • Report
  • May 2025
  • 188 Pages
  • Global
From
Biologics Contract Development & Manufacturing Organization Market by Service Type, Expression System, Therapeutic Category, Development Phase, End User - Global Forecast to 2030 - Product Thumbnail Image

Biologics Contract Development & Manufacturing Organization Market by Service Type, Expression System, Therapeutic Category, Development Phase, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 192 Pages
  • Global
From
Biologics Outsourcing Market by Service Type, Therapeutic Area, Process Stage, Outsourcing Model, End User - Global Forecast to 2030 - Product Thumbnail Image

Biologics Outsourcing Market by Service Type, Therapeutic Area, Process Stage, Outsourcing Model, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 180 Pages
  • Global
From
Vaccine Adjuvants Market by Application, Delivery Route, End User, Adjuvant Type, Formulation, Vaccine Category - Global Forecast to 2030 - Product Thumbnail Image

Vaccine Adjuvants Market by Application, Delivery Route, End User, Adjuvant Type, Formulation, Vaccine Category - Global Forecast to 2030

  • Report
  • May 2025
  • 197 Pages
  • Global
From
Biopharmaceutical CMO & CRO Market by Service Type, Product Type, Application, End User - Global Forecast to 2030 - Product Thumbnail Image

Biopharmaceutical CMO & CRO Market by Service Type, Product Type, Application, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 191 Pages
  • Global
From
Respiratory Disease Vaccine Market by Vaccine Type, Age Group, Distribution Channel, End User, Route Of Administration - Global Forecast to 2030 - Product Thumbnail Image

Respiratory Disease Vaccine Market by Vaccine Type, Age Group, Distribution Channel, End User, Route Of Administration - Global Forecast to 2030

  • Report
  • May 2025
  • 183 Pages
  • Global
From
Cancer Biologics Market by Product Type, Cancer Type, End User, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Cancer Biologics Market by Product Type, Cancer Type, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 190 Pages
  • Global
From
DNA Vaccine Market by Type, Application, End-User, Delivery Method, Technology, Therapeutic Area, Route of Administration - Global Forecast 2025-2030 - Product Thumbnail Image

DNA Vaccine Market by Type, Application, End-User, Delivery Method, Technology, Therapeutic Area, Route of Administration - Global Forecast 2025-2030

  • Report
  • October 2024
  • 196 Pages
From
Vaccine Market Size, Share & Trends Analysis Report By Type (Subunit, mRNA), By Route Of Administration (Oral), By Disease Indication (HPV, MMR), By Age Group (Adult), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Vaccine Market Size, Share & Trends Analysis Report By Type (Subunit, mRNA), By Route Of Administration (Oral), By Disease Indication (HPV, MMR), By Age Group (Adult), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • July 2024
  • 180 Pages
  • Global
From
HIV Vaccines Market by Vaccine Type, Technology, Route of Administration, End User, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

HIV Vaccines Market by Vaccine Type, Technology, Route of Administration, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030 - Product Thumbnail Image

mRNA Therapeutics Market by Technology Platform, Therapeutic Application, Delivery Method - Global Forecast to 2030

  • Report
  • May 2025
  • 185 Pages
  • Global
From
BCMA-targeted CAR-T Cell Therapy Market by Product Type, Line Of Therapy, End User, Distribution Channel, Manufacturing Type - Global Forecast to 2030 - Product Thumbnail Image

BCMA-targeted CAR-T Cell Therapy Market by Product Type, Line Of Therapy, End User, Distribution Channel, Manufacturing Type - Global Forecast to 2030

  • Report
  • May 2025
  • 195 Pages
  • Global
From
Translational Regenerative Medicine Market by Product Type, Therapeutic Approach, Application, End User - Global Forecast to 2030 - Product Thumbnail Image

Translational Regenerative Medicine Market by Product Type, Therapeutic Approach, Application, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
Loading Indicator

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases. Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field. The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more